3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
11
Fallopian Tube Neoplasms
9
Neuroblastoma
6
Neoplasm Metastasis
3
Lung Neoplasms
3
Ganglioneuroblastoma
3
Carcinoma, Ovarian Epithelial
3
Uterine Cervical Neoplasms
2
Sarcoma, Ewing
2
Rhabdoid Tumor
2
Recurrence
2
Leukemia, Myeloid, Acute
2
Glioma
2
Central Nervous System Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
SCLC
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Pediatric Brain Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Interventions
Cyclophosphamide
18
fludarabine phosphate
12
pembrolizumab
11
Nivolumab
11
Brentuximab Vedotin
11
Mycophenolic Acid
10
Doxorubicin
10
fludarabine
9
Dacarbazine
9
Whole-Body Irradiation
8
Etoposide
8
Vinblastine
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Filgrastim
7
Cyclosporine
7
Granulocyte Colony-Stimulating Factor
6
Sirolimus
5
Radiotherapy
5
Peripheral Blood Stem Cell Transplantation
5
Melphalan
5
Gemcitabine
5
Busulfan
5
Tacrolimus
4
pegfilgrastim
3
Vinorelbine
3
Stem Cell Transplantation
3
Rituximab
3
Radiation
3
Prednisone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Topotecan
×
90 days
×
Clear all
No trials found.